BCG Vaccine Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Merck, Serum Institute of India, Sanofi Pasteur, Japan BCG Lab, China National Biotec) | Forecast to 2025

Global BCG Vaccine Market Synopsis:

The exclusive research report on the Global BCG Vaccine Market 2021-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global BCG Vaccine Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

The Global BCG Vaccine Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, BCG Vaccine market size to maintain the average annual growth rate of 0.0525193538143 from $240.0 Million in 2015 to $310.0 Million in 2019, market analysts believe that in the next few years, BCG Vaccine market size will be further expanded, we expect that by 2025, The market size of the BCG Vaccine will reach $410.0 Million.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/286693 .

According to the market research study, the BCG (Bacillus Calmette Gurrin) Vaccine is the only vaccine available for the prevention of Tuberculosis (TB). This vaccine is generally administered to children at birth in countries with high incidence of Tuberculosis (TB).

The most important key factors driving the growth of the Global BCG Vaccine Market are rapid growth in the prevalence of tuberculosis and increase in technological advancements in vaccine research.

Significant points in table of contents: Market Definition, Market Overview, Business Introduction, Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation (Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost Analysis, and Conclusion. The BCG Vaccine Market is segmented based on Product, source, application and Regions. On the basis of product, the market is sub-segmented.

Regionally, North America and Europe holds major share in Global BCG Vaccine Market. Moreover, Asia-Pacific is expected to record higher growth rate in BCG Vaccine market during the forecast year.

Top Major Key Players in the Global BCG Vaccine Market:

1 Merck

2 Sanofi Pasteur

3 Japan BCG Lab

4 China National Biotec

5 Serum Institute of India

6 Intervax

7 GSBPL and More………….

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global BCG Vaccine Market Report 2021” @ https://www.businessindustryreports.com/buy-now/286693/single .

Product Type Segmentation

1 Immune BCG

2 Therapy BCG

Industry Segmentation

1 Hospitals

2 Clinics

International Medical Industry News:

Serum Institute of India (March 15, 2021) - World Health Organisation (WHO) grants Emergency Use Listing (EUL) for the AstraZeneca/Oxford COVID-19 vaccine manufactured by Serum Institute of India - AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age and older, including those over 65.

The authorisation of COVID-19 Vaccine AstraZeneca manufactured by AstraZeneca, and COVISHIELD manufactured by Serum Institute of India (SII), enables global access to the vaccine during the pandemic.

The EUL allows for two doses of the vaccine to be administered at a four to 12-week interval. This regimen was shown in clinical trials to be safe and effective in preventing symptomatic COVID-19, with no severe cases and no hospitalisations more than 14 days after the second dose. The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) recommended a dosing interval of eight to 12 weeks. In addition, they also recommended use of the vaccine in countries where new variants, including the South African B1.351 variant, are prevalent.

AstraZeneca and SII will now work with the COVAX Facility to begin supplying the vaccine around the world, with the majority going to low and middle-income countries as quickly as possible. In the first half of 2021, it is hoped that more than 300 million doses of the vaccine will be made available to 145 countries through COVAX, pending supply and operational challenges. These doses will be allocated equitably according to the COVAX Allocation Framework.

Pascal Soriot, Chief Executive Officer, said: “Today’s approval endorses that the vaccine can be used to help protect populations across the world, including adults over 65 years and in countries where different variants of the SARS-CoV-2 virus are in circulation. This is a huge step towards ensuring global access to our vaccine and helping us fulfil our public health commitment to broad and equitable access at no profit during the pandemic.”

Adar Poonawalla, Chief Executive Officer, Serum Institute of India, said: “We have been waiting for this final milestone. I am happy and relieved that with the WHO's EUL we will be able to start the deliveries to African and other low and middle-income countries immediately. Countries with a large population must be protected as soon as possible.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/286693 .

Major Points in Table of Contents:

Global BCG Vaccine Market Report 2021

1 BCG Vaccine Product Definition

2 Global BCG Vaccine Market Manufacturer Share and Market Overview

2.1 Global Manufacturer BCG Vaccine Shipments

2.2 Global Manufacturer BCG Vaccine Business Revenue

2.3 Global BCG Vaccine Market Overview

2.4 COVID-19 Impact on BCG Vaccine Industry

3 Manufacturer BCG Vaccine Business Introduction

3.1 Merck BCG Vaccine Business Introduction

3.2 Sanofi Pasteur BCG Vaccine Business Introduction

3.3 Japan BCG Lab BCG Vaccine Business Introduction

3.4 China National Biotec BCG Vaccine Business Introduction

3.5 Serum Institute of India BCG Vaccine Business Introduction

3.6 Intervax BCG Vaccine Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.